Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

9.0%

11 terminated/withdrawn out of 122 trials

Success Rate

87.1%

+0.6% vs industry average

Late-Stage Pipeline

13%

16 trials in Phase 3/4

Results Transparency

58%

43 of 74 completed trials have results

Key Signals

19 recruiting43 with results9 terminated

Enrollment Performance

Analytics

Phase 1

46(45.5%)

Phase 2

29(28.7%)

Phase 3

13(12.9%)

N/A

10(9.9%)

Phase 4

3(3.0%)

101Total

Phase 1(46)

Phase 2(29)

Phase 3(13)

N/A(10)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (122)

Showing 20 of 122 trials

NCT07379684Phase 1Recruiting

A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections

Role: collaborator

NCT03877926Phase 3Completed

VELOCITY: An Anthrax Vaccine Clinical Study

Role: collaborator

NCT07565090Phase 1Not Yet Recruiting

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

Role: collaborator

NCT06672978Phase 2Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis

Role: collaborator

NCT07035769Phase 1Recruiting

A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults

Role: collaborator

NCT05586152Phase 1Completed

Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease

Role: collaborator

NCT06925321Phase 3Recruiting

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

Role: collaborator

NCT05421858Phase 3Recruiting

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

Role: collaborator

NCT06808646Phase 1Completed

A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin

Role: collaborator

NCT07425821Phase 1Recruiting

A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

Role: collaborator

NCT06417853Phase 1Completed

Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

Role: collaborator

NCT06701669Phase 2Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

Role: collaborator

NCT06701682Phase 2Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

Role: collaborator

NCT06703073Phase 2Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

Role: collaborator

NCT06701656Phase 2Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

Role: collaborator

NCT07128615Phase 1Active Not Recruiting

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

Role: collaborator

NCT06719219Phase 1Completed

A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.

Role: collaborator

NCT06961708Phase 1Completed

A Study of Fosmanogepix in Healthy Adult Chinese Subjects

Role: collaborator

NCT06036602Phase 2Completed

Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Role: collaborator

NCT05997264Phase 2Active Not Recruiting

Anthrax AV7909 Boost Evaluation Study

Role: lead